Article

Corneal cross-linking effective for keratoconus relapse after penetrating keratoplasty

Author(s):

A recent study demonstrates the safety and efficacy of treating eyes with cross-linking after keratoconus relapses following keratoplasty.

(Image Credit: AdobeStock/Zarina Lukash)

(Image Credit: AdobeStock/Zarina Lukash)

Treating eyes with cross-linking (CXL) after keratoconus relapses following keratoplasty is safe and effective and results in stabilization of the vision,1 according to Noa Kapelushnik, MD, and Noa Avni-Zauberman, MD, the study’s lead authors. They are from the Goldschleger Eye Institute, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Hashomer, Israel.

While this scenario is rare, visual deterioration and corneal graft thinning can result. To preclude that the authors advised that a corneal stabilizing treatment be performed.

They evaluated the safety and efficacy of this approach in a retrospective analysis of eyes in which keratoconus relapsed after a penetrating keratoplasty and the eyes were treated with CXL.

The main outcome measures were the changes in maximal keratometry (Kmax), best-corrected distance visual acuity (BCVA), thinnest corneal thickness (TCT), and central corneal thickness (CCT), and the development of complications.

The investigators identified 10 consecutive eyes of 9 patients in whom keratoconus relapsed after penetrating keratoplasty.

In these eyes, the preoperative median BCVA before the CXL and 1 year after the CXL procedure remained stable (P = 0.68). The median (interquartile range) of the Kmax improved from 63.2 (24.9) diopters (D) before the CXL procedure to 62.2 (27.1) D at 1 year postoperatively (P = 0.028). The median TCT and CCT did not change significantly 1 year after CXL. No complications developed after the procedure, the authors reported.

Investigators concluded that CXL in eyes with keratoconus relapse after keratoplasty is a safe and effective procedure that enables visual stabilization and might results in improved keratometry. Routine follow-up after keratoplasty should be performed to detect early relapses of keratoconus. CXL should be performed in a timely fashion when a relapse is documented.

Reference
1. Kapelushnik N, Avni-Zauberman N, Herber R, et al. Corneal cross-linking for treatment of keratoconus relapse in post-keratoplasty eyes. Int Ophthalmol. 2023; published online July 12; https://doi.org/10.1007/s10792-023-02807-x

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
Lana Rifkin, MD, uveitis committee chair at EnVision Summit 2025
© 2025 MJH Life Sciences

All rights reserved.